Where it is registered
Each register with its number of medicines and a few of them.
Spain
AEMPS · 6 medicines
- Epclusa 150 MG/37,5 MG Granulado Recubierto en Sobre150 mg + 37,5 mg · granulado recubierto · Gilead Sciences Ireland Unlimited Company
- Epclusa 200 MG/50 MG Granulado Recubierto en Sobre200 mg + 50 mg · granulado recubierto · Gilead Sciences Ireland Unlimited Company
- Epclusa 400 MG/100 MG Comprimidos Recubiertos con Pelicula400 mg + 100 mg · comprimido recubierto con pelÃcula · Gilead Sciences Ireland Unlimited Company
- Epclusa 400 MG/100 MG Comprimidos Recubiertos con Pelicula400 mg + 100 mg · comprimido recubierto con pelÃcula · Gilead Sciences Ireland Unlimited Company
Netherlands
CBG-MEB · 6 medicines
- Epclusa 150 mg/37,5 mg, omhuld granulaat in sachetOmhuld granulaat · Gilead Sciences Ireland UC
- Epclusa 200 mg/50 mg filmomhulde tabletFilmomhulde tablet · Gilead Sciences Ireland UC
- Epclusa 200 mg/50 mg, omhuld granulaat in sachetOmhuld granulaat · Gilead Sciences Ireland UC
- Epclusa 400 mg/100 mg filmomhulde tabletFilmomhulde tablet · Gilead Sciences Ireland UC
All medicines with Velpatasvir
Every register, a page at a time. Strengths and packs are on each medicine’s page.
33 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| VoseviCombination | United States | 400MG; 100MG; 100MG | tablet | Marketed | Gilead Sciences INC |
| VoseviCombination | European Union | Authorised | Gilead Sciences Ireland UC | ||
| EpclusaCombination | United States | 150MG; 37.5MG/PACKET, 200MG; 50MG/PACKET | pellets | Marketed | Gilead Sciences INC |
| EpclusaCombination | United States | 200MG; 50MG, 400MG; 100MG | tablet | Marketed | Gilead Sciences INC |
| Vosevi 400 MG/100 MG/100 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 400 mg + 100 mg + 100 mg | comprimido recubierto con pelÃcula | Marketed | Gilead Sciences Ireland Unlimited Company |
| VoseviCombination | Italy | Compressa rivestita con film | Authorised | Gilead Sciences Ireland Uc | |
| EpclusaCombination | European Union | Authorised | Gilead Sciences Ireland UC | ||
| Epclusa 150 MG/37,5 MG Granulado Recubierto en SobreCombination | Spain | 150 mg + 37,5 mg | granulado recubierto | Marketed | Gilead Sciences Ireland Unlimited Company |
| Epclusa 200 MG/50 MG Granulado Recubierto en SobreCombination | Spain | 200 mg + 50 mg | granulado recubierto | Marketed | Gilead Sciences Ireland Unlimited Company |
| Epclusa 400 MG/100 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 400 mg + 100 mg | comprimido recubierto con pelÃcula | Marketed | Gilead Sciences Ireland Unlimited Company |
| Epclusa 400 MG/100 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 400 mg + 100 mg | comprimido recubierto con pelÃcula | Marketed | Gilead Sciences Ireland Unlimited Company |
| Epclusa 400 MG/100 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 400 mg + 100 mg | comprimido recubierto con pelÃcula | Marketed | Gilead Sciences Ireland Unlimited Company |
| Vosevi 200 mg/50 mg/50 mg, filmomhulde tablettenCombination | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Vosevi 400 mg/100 mg/100 mg, filmomhulde tablettenCombination | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| VoseviCombination | Canada | 400 MG + 100 MG + 100 MG | Tablet | Marketed | Gilead Sciences Canada INC |
| EpclusaCombination | Italy | Compressa rivestita con film | Authorised | Gilead Sciences Ireland Uc | |
| Epclusa 150 mg/37,5 mg, omhuld granulaat in sachetCombination | Netherlands | Omhuld granulaat | Authorised | Gilead Sciences Ireland UC | |
| Epclusa 200 mg/50 mg filmomhulde tabletCombination | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Epclusa 200 mg/50 mg, omhuld granulaat in sachetCombination | Netherlands | Omhuld granulaat | Authorised | Gilead Sciences Ireland UC | |
| Epclusa 400 mg/100 mg filmomhulde tabletCombination | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| VoseviCombination | Brazil | Authorised | Gilead Sciences Farmaceutica do Brasil Ltda | ||
| EpclusaCombination | Canada | 400 MG + 100 MG | Tablet | Marketed | Gilead Sciences Canada INC |
| Vosevi Film-Coated Tablets 400MG/100MG/100MGCombination | Singapore | 400 mg + 100 mg + 100 mg | tablet, film coated | Authorised | Gilead Sciences Singapore Pte. LTD. |
| VoseviCombination | Croatia | Marketed | |||
| EpclusaCombination | Brazil | Authorised | Gilead Sciences Farmaceutica do Brasil Ltda |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
- Gilead Sciences Ireland UC14 medicines
- Gilead Sciences Ireland Unlimited Company6 medicines
- Gilead Sciences, Inc.3 medicines
- Gilead Sciences Canada Inc2 medicines
- Gilead Sciences Singapore Pte. Ltd.2 medicines
- Gilead Sciences Farmaceutica Do Brasil Ltda2 medicines
- Gilead Sciences International Ltd1 medicine
- Medicopharmacia Doo Beograd1 medicine
Often combined with
Substances it shares a medicine with.
Names in the registers
How the registers write it, in their own languages.
- Velpatasvirum
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 12
- Medicines
- 33
- Companies
- 8